Novavax, based in Gaithersburg, Maryland, announced a setback this week in its quest for U.S. Food and Drug Administration emergency use authorization of its COVID-19 vaccine.
Alyssa Schukar/Redux
By Meredith WadmanAug. 6, 2021 , 6:15 PM
Novavax, the small,…
COVID-19 vaccinemaker Novavax faces manufacturing setback – Science Magazine
Share this article
More News



Bitcoin drops 18% in seven days, breaking its summer low
November 21, 2026

Crypto Fear Reaches Extreme Levels as Bitcoin Plummets to $55K
November 21, 2026



Santiment Reveals the 5 Most Discussed Topics in Crypto This Week
November 21, 2026